- Accounts
- About
- Trading
- Platforms
- Tools
- News & education
- News & education
- News & analysis
- Education hub
- Economic calendar
World’s largest healthcare company, UnitedHealth Group Inc. (NYSE: UNH), reported fourth quarter and 2023 full-year financial results on Friday.
The company achieved revenue of $94.427 billion for Q4 of 2023 (up by 14% vs. Q4 2022) vs. $92.126 billion expected.
Earnings per share (EPS) reported at $6.16 per share vs. estimate of $5.985 per share.
Full-year revenue reached $371.6 billion, up by 15% vs. 2022.
EPS reported at $25.12 per share, up by 13.2% year-over-year.
Company’s medical costs rose by 16.1% from $53.591 billion to $62.231 billion.
Company overview
CEO commentary
“UnitedHealth Group enters 2024 well prepared to build on our efforts to improve patient care and consumer experiences broadly, and to continue delivering strong and balanced growth,” Andrew Witty, CEO of the company highlighted on what the company is focusing on in the year ahead.
Stock reaction
Shares of UnitedHealth were down by around 3% on Friday despite beating analyst estimates for the quarter due to rising operating costs.
Stock performance
UnitedHealth stock price targets
UnitedHealth Group Inc. is the 15th largest company in the world with a market cap of $481.23 billion.
You can trade UnitedHealth Group Inc. (NYSE: UNH) and many other stocks from the NYSE, NASDAQ, HKEX and ASX with GO Markets as a Share CFD on the MetaTrader 5 platform. To find out more, go to ”Trading” then select ”Share CFDs”.
GO Markets offers pre-market and after-market trading on popular US Share CFDs.
Why trade during extended hours?
Sources: UnitedHealth Group Inc., TradingView, MarketWatch, MarketBeat, CompaniesMarketCap
Disclaimer: Articles are from GO Markets analysts and contributors and are based on their independent analysis or personal experiences. Views, opinions or trading styles expressed are their own, and should not be taken as either representative of or shared by GO Markets. Advice, if any, is of a ‘general’ nature and not based on your personal objectives, financial situation or needs. Consider how appropriate the advice, if any, is to your objectives, financial situation and needs, before acting on the advice. If the advice relates to acquiring a particular financial product, you should obtain and consider the Product Disclosure Statement (PDS) and Financial Services Guide (FSG) for that product before making any decisions.
FX traders come into the new week with an uptick in tier one economic releases to look forward to after a very slow start to the year volatility-wise. Australian and US employment figures, UK CPI and US retail sales look to headline from Tuesday onwards (Monday is a US public holiday) The Charts to watch: AUDUSD AUDUSD has struggled to fin...
Bank of America Corp. (NYSE: BAC) announced Q4 2023 financial results before the opening bell in Wall Street on Friday. The US bank reported revenu...